Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant fusion protein linking coagulation factor VIIa with albumin

EU orphan designation number: EU/3/13/1188   
Active ingredient: Recombinant fusion protein linking coagulation factor VIIa with albumin
Indication: Treatment of congenital factor VII deficiency
Sponsor: CSL Behring GmbH
Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Centralised Orphan - Designation EMA/OD/051/13 (2013)6733 of 07/10/2013